QQ客服 官方微博 反馈留言

	P53 status as a biomarker to predict the response to neoadjuvant therapy in esophageal cancer: a systematic review and meta-analysis
	Xu, Hai-Yuan[1]; Su, Zhao-Liang[2]; Li, Xing[3]; Chen, Min-Bin[4]; Ji, Zhang-Yi[5]; Lu, Xiang-Rong[6]
刊名	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
	2017
卷号	10期号:2页码:890-900
关键词	P53 biomarker neoadjuvant therapy esophageal cancer
ISSN号	1936-2625
URL标识	查看原文
收录类别	SCI(E)
WOS记录号	WOS:000395739000006
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5355310
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, 91 Qianjin Rd, Kunshan 215300, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Inst Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 3.[3]Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Chest Surg, 91 Qianjin Rd, Kunshan 215300, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, 91 Qianjin Rd, Kunshan 215300, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, 91 Qianjin Rd, Kunshan 215300, Jiangsu, Peoples R China. 6.[6]Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Orthopaed, 91 Qianjin Rd, Kunshan 215300, Jiangsu, Peoples R China.
推荐引用方式 GB/T 7714	Xu, Hai-Yuan[1],Su, Zhao-Liang[2],Li, Xing[3],et al. P53 status as a biomarker to predict the response to neoadjuvant therapy in esophageal cancer: a systematic review and meta-analysis[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,2017,10(2):890-900.
APA	Xu, Hai-Yuan[1],Su, Zhao-Liang[2],Li, Xing[3],Chen, Min-Bin[4],Ji, Zhang-Yi[5],&Lu, Xiang-Rong[6].(2017).P53 status as a biomarker to predict the response to neoadjuvant therapy in esophageal cancer: a systematic review and meta-analysis.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,10(2),890-900.
MLA	Xu, Hai-Yuan[1],et al."P53 status as a biomarker to predict the response to neoadjuvant therapy in esophageal cancer: a systematic review and meta-analysis".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 10.2(2017):890-900.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。